10-K Filing

LifeMD, Inc. CIK: 948320 FY 2020

Filing Information

Form Type	10-K
Accession Number	`0001493152-21-007194`
Period End Date	20201231
Filing Date	20210330
Fiscal Year	2020
Fiscal Period	FY
XBRL Instance	lfmd-20201231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 79 Income Statement 48 Cash Flow Statement 108 Stockholders Equity 34

Balance Sheet 79 line items

Line Item	Tag	Value	Unit	Period
Cash	`CashAndCashEquivalentsAtCarryingValue`	$9.18M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$1.11M	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$97.45K	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$648.42K	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$150.00K	USD	Point-in-time
Product deposit	`DepositsAssetsCurrent`	$816.76K	USD	Point-in-time
Inventory, net	`InventoryNet`	$1.26M	USD	Point-in-time
Inventory, net	`InventoryNet`	$950.06K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$154.88K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$442.97K	USD	Point-in-time
Preferred stock, at par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$2.75M	USD	Point-in-time
Preferred stock, at par value	`TemporaryEquityParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$12.06M	USD	Point-in-time
Preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`TemporaryEquitySharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`TemporaryEquitySharesIssued`	-	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$23.62K	USD	Point-in-time
Preferred stock, shares issued	`TemporaryEquitySharesIssued`	-	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$274.44K	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	$375.98K	USD	Point-in-time
Capitalized software, net	`CapitalizedComputerSoftwareNet`	-	USD	Point-in-time
Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`TemporaryEquitySharesOutstanding`	-	shares	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$339.84K	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$675.45K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$990.26K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$699.08K	USD	Point-in-time
Total Assets	`Assets`	$13.05M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Total Assets	`Assets`	$3.45M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	23.43M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.68M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.58M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	23.33M	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$11.79M	USD	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Treasury stock, shares	`TreasuryStockCommonShares`	103,040.00	shares	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.05M	USD	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$814.73K	USD	Point-in-time
Notes payable, net	`NotesPayableCurrent`	$779.13K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$916.88K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$109.55K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$3.98M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$13.49M	USD	Point-in-time
Lease Liability	`OperatingLeaseLiability`	$29.98K	USD	Point-in-time
Lease Liability	`OperatingLeaseLiability`	$285.32K	USD	Point-in-time
Contingent consideration on purchase of LegalSimpli	`ContingentConsiderationOnPurchaseOfLegalsimpli`	$500.00K	USD	Point-in-time
Contingent consideration on purchase of LegalSimpli	`ContingentConsiderationOnPurchaseOfLegalsimpli`	$100.00K	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	-	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$70.00K	USD	Point-in-time
Total Liabilities	`Liabilities`	$4.58M	USD	Point-in-time
Total Liabilities	`Liabilities`	$13.88M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred Stock, $0.0001 per value; 4,996,500 and 5,000,000 shares authorized Series B Preferred Stock, $0.0001 per value; 5,000 and 0 shares authorized, 3,500 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively; liquidation value approximately, $1,045 and $0 per share at December 31, 2020 and 2019, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$3.66M	USD	Point-in-time
Preferred Stock, $0.0001 per value; 4,996,500 and 5,000,000 shares authorized Series B Preferred Stock, $0.0001 per value; 5,000 and 0 shares authorized, 3,500 and 0 shares issued and outstanding as of December 31, 2020 and 2019, respectively; liquidation value approximately, $1,045 and $0 per share at December 31, 2020 and 2019, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	-	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 23,433,663 and 10,680,730 shares issued, 23,330,623 and 10,577,690 outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$106.81K	USD	Point-in-time
Common stock, $0.01 par value; 100,000,000 shares authorized, 23,433,663 and 10,680,730 shares issued, 23,330,623 and 10,577,690 outstanding as of December 31, 2020 and 2019, respectively	`CommonStockValue`	$234.34K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$77.78M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$15.66M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-80.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-16.59M	USD	Point-in-time
Equity	`EquityTotal`	$-824.48K	USD	Point-in-time
Equity	`EquityTotal`	$-2.14M	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Treasury stock, 103,040 and 103,040 shares, at cost	`TreasuryStockValue`	$163.70K	USD	Point-in-time
Total LifeMD, Inc. Stockholders' Deficit	`StockholdersEquity`	$-988.18K	USD	Point-in-time
Total LifeMD, Inc. Stockholders' Deficit	`StockholdersEquity`	$-2.30M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-2.18M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$-141.06K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$819.74K	USD	Point-in-time
Total Stockholders' Deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.13M	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$3.45M	USD	Point-in-time
Total Liabilities and Stockholders' Deficit	`LiabilitiesAndStockholdersEquity`	$13.05M	USD	Point-in-time

Income Statement 48 line items

Line Item	Tag	Value	Unit	Period
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$12.47M	USD	Annual
Total revenues, net	`RevenueFromContractWithCustomerExcludingAssessedTax`	$37.29M	USD	Annual
Cost of revenues	`CostOfRevenue`	$2.53M	USD	Annual
Cost of revenues	`CostOfRevenue`	$8.91M	USD	Annual
Gross Profit	`GrossProfit`	$9.94M	USD	Annual
Gross Profit	`GrossProfit`	$28.39M	USD	Annual
Selling & marketing expenses	`SellingAndMarketingExpense`	$8.92M	USD	Annual
Selling & marketing expenses	`SellingAndMarketingExpense`	$41.67M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$42.21M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$2.40M	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$1.17M	USD	Annual
Other operating expenses	`OtherGeneralExpense`	$724.27K	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$570.76K	USD	Annual
Customer service expenses	`OtherSellingGeneralAndAdministrativeExpense`	$716.33K	USD	Annual
Development Costs	`DevelopmentCosts`	$446.75K	USD	Annual
Development Costs	`DevelopmentCosts`	$222.88K	USD	Annual
Total expenses	`OperatingExpenses`	$86.21M	USD	Annual
Total expenses	`OperatingExpenses`	$12.83M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-2.89M	USD	Annual
Operating Loss	`OperatingIncomeLoss`	$-57.82M	USD	Annual
Interest expense, net	`InterestExpense`	$1.67M	USD	Annual
Interest expense, net	`InterestExpense`	$761.15K	USD	Annual
Loss on debt settlement	`GainsLossesOnExtinguishmentOfDebt`	$-914.86K	USD	Annual
Loss on debt settlement	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Total	`NonoperatingIncomeExpense`	$-761.15K	USD	Annual
Total	`NonoperatingIncomeExpense`	$-2.58M	USD	Annual
Net Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-60.40M	USD	Annual
Net Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.65M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$122.50K	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$-122.50K	USD	Annual
Net Loss	`ProfitLoss`	$-3.53M	USD	Annual
Net Loss	`ProfitLoss`	$-60.52M	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-391.06K	USD	Annual
Net (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.88M	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-58.65M	USD	Annual
Net loss attributable to LifeMD, Inc.	`NetIncomeLoss`	$-3.14M	USD	Annual
Deemed distribution to holders of common and Series B Preferred stock	`PreferredStockDividendsAndOtherAdjustments`	$4.72M	USD	Annual
Deemed distribution to holders of common and Series B Preferred stock	`PreferredStockDividendsAndOtherAdjustments`	-	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-63.36M	USD	Annual
Net loss attributable to LifeMD, Inc. common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.14M	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-0.32	USD	Annual
Basic loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerBasicShare`	$-4.44	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-0.32	USD	Annual
Diluted loss per share attributable to LifeMD, Inc. common stockholders	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-4.44	USD	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	9.90M	shares	Annual
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	14.28M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	14.28M	shares	Annual
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	9.90M	shares	Annual

Cash Flow Statement 108 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`ProfitLoss`	$-3.53M	USD	Annual
Net Loss	`ProfitLoss`	$-60.52M	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$622.26K	USD	Annual
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$817.12K	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	-	USD	Annual
Amortization of capitalized software	`CapitalizedComputerSoftwareAmortization1`	$62.15K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$335.61K	USD	Annual
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$335.61K	USD	Annual
Acceleration of debt discount	`AccelerationOfDebtDiscount`	$500.14K	USD	Annual
Acceleration of debt discount	`AccelerationOfDebtDiscount`	-	USD	Annual
Loss on debt settlement	`GainsLossesOnExtinguishmentOfDebt`	$-914.86K	USD	Annual
Loss on debt settlement	`GainsLossesOnExtinguishmentOfDebt`	-	USD	Annual
Operating Lease Payments	`OperatingLeasePayments`	$4.53K	USD	Annual
Operating Lease Payments	`OperatingLeasePayments`	$6.35K	USD	Annual
Stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$16.00K	USD	Annual
Stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$18.30M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$18.66M	USD	Annual
Stock compensation expense	`ShareBasedCompensation`	$733.22K	USD	Annual
Deferred tax liability	`DeferredIncomeTaxExpenseBenefit`	$66.00K	USD	Annual
Deferred tax liability	`DeferredIncomeTaxExpenseBenefit`	$-70.00K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-1.60K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$550.97K	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$666.76K	USD	Annual
Product deposit	`IncreaseDecreaseInContractWithCustomerAsset`	$116.69K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$-72.56K	USD	Annual
Inventory	`IncreaseDecreaseInInventories`	$314.20K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-95.59K	USD	Annual
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$172.97K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$807.33K	USD	Annual
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$33.57K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$2.18M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$9.50M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$251.41K	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-12.13M	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	$398.14K	USD	Annual
Cash paid for capitalized software costs	`PaymentsToAcquireSoftware`	-	USD	Annual
Payment to seller for contingent consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$100.00K	USD	Annual
Payment to seller for contingent consideration	`PaymentForContingentConsiderationLiabilityInvestingActivities`	$400.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-100.00K	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-798.14K	USD	Annual
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	-	USD	Annual
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	$14.90M	USD	Annual
Cash proceeds from private placement offering, net	`ProceedsFromIssuanceOfPrivatePlacement`	$14.90M	USD	Point-in-time
Cash proceeds from Series B Preferred Stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	Annual
Cash proceeds from Series B Preferred Stock	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$2.89M	USD	Annual
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	$1.09M	USD	Annual
Proceeds from convertible notes payable	`ProceedsFromConvertibleDebt`	$2.35M	USD	Annual
Cash proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Cash proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$2.34M	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$622.76K	USD	Annual
Cash proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	$302.40K	USD	Annual
Cash proceeds from exercise of options	`ProceedsFromStockOptionsExercised`	-	USD	Annual
Cash proceed from sale of warrants	`ProceedsFromIssuanceOfWarrants`	$25.00K	USD	Annual
Cash proceed from sale of warrants	`ProceedsFromIssuanceOfWarrants`	-	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$15.00K	USD	Annual
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$89.08K	USD	Annual
Distributions to non-controlling interest	`PaymentsToMinorityShareholders`	$157.22K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	$242.00K	USD	Annual
Proceeds from note payable	`ProceedsFromNotesPayable`	-	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$2.50M	USD	Annual
Repayment of notes payable	`RepaymentsOfNotesPayable`	$295.00K	USD	Annual
Purchase of shares and warrants	`PaymentsForRepurchaseOfEquity`	-	USD	Annual
Purchase of shares and warrants	`PaymentsForRepurchaseOfEquity`	$350.00K	USD	Annual
Debt issuance costs	`PaymentsOfLoanCosts`	$284.07K	USD	Annual
Debt issuance costs	`PaymentsOfLoanCosts`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$775.12K	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$21.00M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$8.07M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$926.53K	USD	Annual
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.18M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.11M	USD	Point-in-time
Cash at beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.09K	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$9.18M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.11M	USD	Point-in-time
Cash at end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$180.09K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$80.66K	USD	Annual
Cash paid during the period for interest	`InterestPaidNet`	$1.67M	USD	Annual
Issuance of company stock for investment in subsidiary	`StockIssued1`	-	USD	Annual
Issuance of company stock for investment in subsidiary	`StockIssued1`	$900.00K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrantsSupplementalDisclosure`	$49.55K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrantsSupplementalDisclosure`	-	USD	Annual
Deemed dividend from warrant price adjustments	`DeemedDividendFromWarrantPriceAdjustment`	$1.29M	USD	Annual
Deemed dividend from warrant price adjustments	`DeemedDividendFromWarrantPriceAdjustment`	-	USD	Annual
Deemed distribution from warrants issued with Series B Preferred Stock	`DeemedDistributionFromWarrantsIssuedWithPreferredStock`	$3.50M	USD	Annual
Deemed distribution from warrants issued with Series B Preferred Stock	`DeemedDistributionFromWarrantsIssuedWithPreferredStock`	-	USD	Annual
Stock yet to be issued for capitalized costs	`StockIssuesForCapitalizedCosts`	-	USD	Annual
Stock yet to be issued for capitalized costs	`StockIssuesForCapitalizedCosts`	$40.00K	USD	Annual
Deemed distribution from down-round provision on unissued shares	`DeemedDistributionFromDownroundProvisionOnUnissuedShares`	-	USD	Annual
Deemed distribution from down-round provision on unissued shares	`DeemedDistributionFromDownroundProvisionOnUnissuedShares`	$194.02K	USD	Annual
Liability to issue common stock	`LiabilitiesAssumed1`	$76.35K	USD	Annual
Debt issuance costs for liability to issue shares	`NotesIssued1`	$219.45K	USD	Annual
Debt issuance costs for liability to issue shares	`NotesIssued1`	-	USD	Annual
Conversion of convertible note payable and interest for Series B Preferred Stock	`TransferToInvestments`	-	USD	Annual
Conversion of convertible note payable and interest for Series B Preferred Stock	`TransferToInvestments`	$607.50K	USD	Annual
Stock issued for capitalized costs	`SharesIssuedForShareLiability`	-	USD	Annual
Stock issued for capitalized costs	`SharesIssuedForShareLiability`	$12.68K	USD	Annual
Warrants issued in relation to debt	`WarrantsIssuedInRelationToDebt`	-	USD	Annual
Warrants issued in relation to debt	`WarrantsIssuedInRelationToDebt`	$569.15K	USD	Annual
Common stock issued for conversion of debt	`NotesReduction`	-	USD	Annual
Common stock issued for conversion of debt	`NotesReduction`	$1.12M	USD	Annual
Debt Exchange Agreement	`TransferOfLoansHeldForSaleToPortfolioLoans1`	-	USD	Annual
Debt Exchange Agreement	`TransferOfLoansHeldForSaleToPortfolioLoans1`	$250.00K	USD	Annual
Right of Use asset	`RightOfUseAsset`	$274.44K	USD	Annual
Right of Use asset	`RightOfUseAsset`	-	USD	Annual
Right of Use lease liability	`CapitalLeaseObligationsIncurred`	-	USD	Annual
Right of Use lease liability	`CapitalLeaseObligationsIncurred`	$285.32K	USD	Annual

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$819.74K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.13M	USD	Point-in-time
Stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$16.00K	USD	Annual
Stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$18.30M	USD	Annual
Stock compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$18.66M	USD	Annual
Stock compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$733.22K	USD	Annual
Agreement to issue shares for non-controlling interest in CVLB PR	`AgreementToIssueSharesForNoncontrollingInterest`	-	USD	Annual
Warrants issued in conjunction with stock	`AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithStock`	$20.82K	USD	Annual
Warrants issued in conjunction with debt	`AdjustmentsToAdditionalPaidInCapitalWarrantsIssuedInConjunctionWithDebt`	$569.15K	USD	Annual
Purchase of common stock	`StockIssuedDuringPeriodValueNewIssues`	$329.18K	USD	Annual
Purchase of common stock	`StockIssuedDuringPeriodValueNewIssues`	$329.18K	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$89.08K	USD	Annual
Distribution to non-controlling interest	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$157.22K	USD	Annual
Sale of warrants	`AdjustmentsToAdditionalPaidInCapitalWarrantIssued`	$25.00K	USD	Annual
Exercise of warrants	`StockIssuedDuringPeriodValueExerciseOfWarrants`	$622.76K	USD	Annual
Exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$302.40K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfWarrants`	-	USD	Annual
Cashless exercise of stock options	`StockIssuedDuringPeriodValueCashlessExerciseOfStockOptions`	-	USD	Annual
Sale of common stock	`StockIssuedDuringPeriodValueSaleOfCommonStock`	$250.00K	USD	Annual
Sale of stock in private placement, net	`StockIssuedDuringPeriodSaleOfStockInPrivatePlacementNet`	$14.90M	USD	Annual
Shares issued for share liability (proceeds received in prior period)	`StockIssuedDuringPeriodValueOther`	$2.18M	USD	Annual
Common stock issued for debt exchange agreement	`StockIssuedDuringPeriodValueConversionOfUnits`	$1.16M	USD	Annual
Common stock issued for conversion of debt	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.12M	USD	Annual
Deemed dividend from down-round provision in common stock shares yet to be issued	`DividendsCommonStockCash`	$194.02K	USD	Annual
Deemed dividend from warrant price adjustments	`WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount`	-	USD	Annual
Deemed dividend from warrants issued and BCF with Series B Preferred Stock	`DividendsPreferredStockCash`	-	USD	Annual
Rounding due to reverse split	`StockIssuedDuringPeriodValueReverseStockSplits`	$6.00	USD	Annual
Rounding due to reverse split, shares	`StockIssuedDuringPeriodSharesReverseStockSplits`	632.00	shares	Point-in-time
Net loss	`ProfitLoss`	$-3.53M	USD	Annual
Net loss	`ProfitLoss`	$-60.52M	USD	Annual
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-4.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$819.74K	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.13M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.